Glutathione (GSH), often referred to as “the master antioxidant,” participates not only in
antioxidant defense systems, but many metabolic processes, and therefore its role cannot be
overstated. GSH deficiency causes cellular risk for oxidative damage and thus as expected,
GSH imbalance is observed in a wide range of pathological conditions including
tuberculosis (TB), HIV, diabetes, cancer, and aging. Consequently, it is not surprising that
GSH has attracted the attention of biological researchers and pharmacologists alike as a …